Literature DB >> 9512476

Determination of functional domains in polypyrimidine-tract-binding protein.

Y L Oh1, B Hahm, Y K Kim, H K Lee, J W Lee, O Song, K Tsukiyama-Kohara, M Kohara, A Nomoto, S K Jang.   

Abstract

Polypyrimidine-tract-binding protein (PTB) is involved in pre-mRNA splicing and internal-ribosomal-entry-site-dependent translation. The biochemical properties of various segments of PTB were analysed in order to understand the molecular basis of the PTB functions. The protein exists in oligomeric as well as monomeric form. The central part of PTB (amino acids 169-293) plays a major role in the oligomerization. PTB contains several RNA-binding motifs. Among them, the C-terminal part of PTB (amino acids 329-530) exhibited the strongest RNA-binding activity. The N-terminal part of PTB is responsible for the enhancement of RNA binding by HeLa cell cytoplasmic factor(s).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512476      PMCID: PMC1219335          DOI: 10.1042/bj3310169

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Signal sequences that target nuclear import and nuclear export of pre-mRNA-binding proteins.

Authors:  W M Michael; H Siomi; M Choi; S Piñol-Roma; S Nakielny; Q Liu; G Dreyfuss
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1995

2.  Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.

Authors:  S van der Werf; J Bradley; E Wimmer; F W Studier; J J Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation.

Authors:  S K Jang; H G Kräusslich; M J Nicklin; G M Duke; A C Palmenberg; E Wimmer
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

4.  The translation initiation factor eIF-4B contains an RNA-binding region that is distinct and independent from its ribonucleoprotein consensus sequence.

Authors:  N Méthot; A Pause; J W Hershey; N Sonenberg
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

5.  Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo.

Authors:  S K Jang; M V Davies; R J Kaufman; E Wimmer
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

6.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

7.  Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins.

Authors:  R Singh; J Valcárcel; M R Green
Journal:  Science       Date:  1995-05-26       Impact factor: 47.728

8.  Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA.

Authors:  A Kaminski; S L Hunt; J G Patton; R J Jackson
Journal:  RNA       Date:  1995-11       Impact factor: 4.942

9.  Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA.

Authors:  J Pelletier; N Sonenberg
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

10.  Identification of the RNA binding segment of human U1 A protein and definition of its binding site on U1 snRNA.

Authors:  D Scherly; W Boelens; W J van Venrooij; N A Dathan; J Hamm; I W Mattaj
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  40 in total

1.  La autoantigen enhances translation of BiP mRNA.

Authors:  Y K Kim; S H Back; J Rho; S H Lee; S K Jang
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

2.  Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3C(pro).

Authors:  Sung Hoon Back; Yoon Ki Kim; Woo Jae Kim; Sungchan Cho; Hoe Rang Oh; Jung-Eun Kim; Sung Key Jang
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 3.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

Review 4.  Polypyrimidine tract binding protein antagonizes exon definition.

Authors:  E J Wagner; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

5.  Identification of cellular proteins enhancing activities of internal ribosomal entry sites by competition with oligodeoxynucleotides.

Authors:  Kobong Choi; Jong Heon Kim; Xiaoyu Li; Ki Young Paek; Sang Hoon Ha; Sung Ho Ryu; Eckard Wimmer; Sung Key Jang
Journal:  Nucleic Acids Res       Date:  2004-02-23       Impact factor: 16.971

6.  ELAV multimerizes on conserved AU4-6 motifs important for ewg splicing regulation.

Authors:  Matthias Soller; Kalpana White
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

7.  Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes: unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit.

Authors:  Mohd Ashraf Dar; Atul Sharma; Neelima Mondal; Suman Kumar Dhar
Journal:  Eukaryot Cell       Date:  2007-01-12

8.  Characterization of multimeric complexes formed by the human PTB1 protein on RNA.

Authors:  Caroline Clerte; Kathleen B Hall
Journal:  RNA       Date:  2006-01-23       Impact factor: 4.942

9.  A polypyrimidine tract binding protein, pumpkin RBP50, forms the basis of a phloem-mobile ribonucleoprotein complex.

Authors:  Byung-Kook Ham; Jeri L Brandom; Beatriz Xoconostle-Cázares; Vanessa Ringgold; Tony J Lough; William J Lucas
Journal:  Plant Cell       Date:  2009-01-02       Impact factor: 11.277

10.  Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus.

Authors:  Hana Cho; Hyung Chul Lee; Sung Key Jang; Yoon Ki Kim
Journal:  Virus Genes       Date:  2008-06-20       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.